Head and Neck Diseases by Alexandros G.Sfakianakis: OtoRhinoLaryngology & Medicine,New Articles,June 5th,2016,a

Κυριακή 5 Ιουνίου 2016

OtoRhinoLaryngology & Medicine,New Articles,June 5th,2016,a

Influence of ACE gene on differential response to sertraline versus fluoxetine in patients with major depression: a randomized controlled trial2016-06-05 12:23:28 AM
Influence of ACE gene on differential response to sertraline versus fluoxetine in patients with major depression: a randomized controlled trial:
Abstract

Background

Extensive distribution of the different components of renin angiotensin system (RAS) in the brain, along with their roles in promoting anxiety, depression and brain inflammation, opposes RAS as a potential therapeutic target in major depression. Actions of angiotensin II, the main product of RAS, are reduced by antidepressants and this signifies the complex interplay of different mechanisms involved in response to therapy. Here, we hypothesized that genetic polymorphisms of RAS may affect the outcome of therapy in depressed patients.

Methods

The frequencies of variants of genes encoding for angiotensin-converting enzyme (ACE) insertion/deletion (I/D), rs4291 and rs4343 polymorphisms were determined in extracted DNAs of 200 newly diagnosed depressed patients. Patients were randomly divided into two groups, one treated with fluoxetine and the other treated with sertraline for 12 weeks. Responsive patients were determined by psychiatrist using Hamilton questionnaire and were compared with regard to their genetic variants.

Results

Carriers of the D allele and patients with DD genotype responded significantly better to sertraline than to fluoxetine (P = 0.0006, odds ratio (OR) = 3.0, 95 % confidence interval (CI) = 1.80–5.08; P = 0.006, OR = 3.7, 95 % CI = 1.66–8.29, respectively). Mutant genotypes (GG and TT) of rs4343 and rs4291 polymorphisms were also more frequent in patients responding to sertraline, though not achieving the significance level (P = 0.162 and P = 0.256, respectively).

Conclusion

These findings suggest that special genetic variants of RAS may influence or be an indicator for better response to sertraline.

from Therapeutics via xlomafota13 on Inoreader
via IFTTT

Read more Add star Mark as unread Top
Diseases and Syndromes that affect the Lungs and Kidneys: A Radiologic Review2016-06-05 12:23:28 AM
Diseases and Syndromes that affect the Lungs and Kidneys: A Radiologic Review:
Publication date: Available online 4 June 2016Source:Current Problems in Diagnostic Radiology
Author(s): Mark M. Hammer, Anup S. Shetty, Elizabeth F. Sheybani, Sanjeev Bhalla
A number of different conditions simultaneously affect both the lungs and kidneys. These include autoimmune disorders and genetic tumor syndromes. While manifestations within either organ system alone may not be specific, by observing the pattern of involvement and clinical history, radiologists may be able to suggest the correct diagnosis.
from Imaging via xlomafota13 on Inoreader
via IFTTT

Read more Add star Mark as unread Top
Cross-cover of oral and maxillofacial surgery out-of-hours: an audit of a new adult treatment clinic2016-06-05 12:21:30 AM

We present our experience of launching the adult treatment clinic - a daytime clinic for semiurgent referrals to oral and maxillofacial surgery (OMFS). This has proved to be an effective way in which cross-covering junior doctors could refer patients for a safe and efficient review in a supervised environment.
from http://ift.tt/1sY1r4y
via IFTTT

from on Inoreader http://ift.tt/1sY2X6O
via IFTTT

Read more Add star Mark as unread Top
Diseases and Syndromes that affect the Lungs and Kidneys: A Radiologic Review2016-06-05 12:15:51 AM

Publication date: Available online 4 June 2016
Source:Current Problems in Diagnostic Radiology
Author(s): Mark M. Hammer, Anup S. Shetty, Elizabeth F. Sheybani, Sanjeev Bhalla
A number of different conditions simultaneously affect both the lungs and kidneys. These include autoimmune disorders and genetic tumor syndromes. While manifestations within either organ system alone may not be specific, by observing the pattern of involvement and clinical history, radiologists may be able to suggest the correct diagnosis.

from Imaging via xlomafota13 on Inoreader http://ift.tt/1t9LskL

Read more Add star Mark as unread Top
Cross-cover of oral and maxillofacial surgery out-of-hours: an audit of a new adult treatment clinic2016-06-05 12:15:51 AM

We present our experience of launching the adult treatment clinic - a daytime clinic for semiurgent referrals to oral and maxillofacial surgery (OMFS). This has proved to be an effective way in which cross-covering junior doctors could refer patients for a safe and efficient review in a supervised environment.

from #ΓναθοΧειρουργική via xlomafota13 on Inoreader http://ift.tt/1sY1r4y

Read more Add star Mark as unread Top
Prognostic value of posttreatment neutrophil–lymphocyte ratio in head and neck squamous cell carcinoma treated by chemoradiotherapy2016-06-05 12:14:55 AM

Prognostic value of posttreatment neutrophil–lymphocyte ratio in head and neck squamous cell carcinoma treated by chemoradiotherapy: An inflammatory-immunological marker, C-reactive protein (CRP), neutrophil-to-lymphocyte ratio (NLR), was evaluated as a predictive marker of advanced head and neck cancer patients receiving chemoradiotherapy.

Abstract

Objective

An inflammatory-immunological marker, C-reactive protein (CRP), neutrophil-to-lymphocyte ratio (NLR), was evaluated as a predictive marker of advanced head and neck cancer patients receiving chemoradiotherapy.

Methods

This study included 104 patients with treatment-naïve head and neck cancer who underwent definitive chemoradiotherapy. An inflammatory marker was measured at baseline and after 1 month of treatment. Univariate and multivariate analyses using Cox proportional hazards model were used to identify predictors of progression-free survival (PFS) and overall survival (OS).

Results

A univariate analysis revealed that T,N-stage, the pre- and posttreatment NLRs were significant predictors of progression after the chemoradiotherapy. However, the posttreatment NLR remained an independent predictor of PFS in the multivariate analysis (HR = 2.23, 95% CI 1.15–2.321; P = 0.001). A high posttreatment NLR was significantly associated with an increased risk of death (HR = 1.87, 95% CI 0.89–3.31; P = 0.037).

Conclusion

A high posttreatment NLR is associated with poor prognostic factor. An early reduction in the NLR after treatment may indicate survival improvement in the patients.

Keywords:
Head and neck squamous cell carcinomas, Chemoradiotherapy, Prognosis, Neutrophil–lymphocyte ratio

from OtoRhinoLaryngology - Alexandros G. Sfakianakis http://ift.tt/1XtxVB3
via IFTTT

Read more Add star Mark as unread Top
Advances in eyelid reconstruction.2016-06-05 12:14:55 AM

Advances in eyelid reconstruction.: Purpose of review: To describe the principles of eyelid reconstruction that must balance aesthetic and functional concerns of one of the most important areas of physical beauty on the human body. Our review seeks to give an overview of how to utilize a variety of techniques along the reconstructive ladder from direct closure to complex grafts and local flaps.

Recent findings: We describe novel modifications of existing flaps that have been traditionally used in eyelid reconstruction along with analysis of many time honored techniques and current research in improving our understanding of the factors which allow a successful reconstruction.

Summary: A familiarity with the variety of options for reconstruction will give the surgeon the fluidity to analyze a defect and choose the best possible method.

Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.

from OtoRhinoLaryngology - Alexandros G. Sfakianakis http://ift.tt/1r86Gxi
via IFTTT

Read more Add star Mark as unread Top
New biomaterials versus traditional techniques: advances in cleft palate reconstruction.2016-06-05 12:14:55 AM

New biomaterials versus traditional techniques: advances in cleft palate reconstruction.: Purpose of review: Cleft lip and palate still remains one of the most common congenital anomalies, and consequently surgical correction of these anomalies is still commonplace. Despite numerous existing surgical techniques having good outcomes, it is still recognized that the morbidity of certain surgical procedures and success rates regarding outcomes can be improved. The purpose of this review is to evaluate new literature and techniques compared with the time tested procedures that are commonly used.

Recent findings: As technology continues to advance, the understanding of details regarding biochemical pathways responsible for the development of cleft defects and also the efficacy of biomaterials that can be used in their correction are being discovered and better understood. Many studies have been conducted in both animal and human study participants that further the understanding of these questions. The efficacy and benefit of newly devised biomaterials seems to indicate that these biomaterials are a viable adjunct and often an alternative in the treatment of cleft palate patients.

Summary: In this review of recent literature, the discussion begins with a review of the more traditional and widely accepted iliac crest bone grafting and then evolves into a discussion of several animal and human studies to delineate the progress being made in this field. The literature exploring the details regarding biochemical pathways and cellular mediators that are involved in cleft formation, as well as biomaterials used in surgical repair are evaluated. The findings in the literature suggest that there is a bright future in better understanding the cause of cleft formation on a molecular level and associated attempts that can be made in altering some of these factors along with discovering new biomaterials that can be a useful adjunct to existing techniques.

Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.

from OtoRhinoLaryngology - Alexandros G. Sfakianakis http://ift.tt/1XtylHJ
via IFTTT

Read more Add star Mark as unread Top
Simulation in craniomaxillofacial training.2016-06-05 12:14:55 AM

Simulation in craniomaxillofacial training.: Purpose of review: Simulation in healthcare is no longer a novel idea. Simulation continues to rapidly permeate and transform both clinical practice and medical education. Craniomaxillofacial surgery is comprised of multiple surgical disciplines, including neurosurgery, plastic surgery, otolaryngology, ophthalmology, and oral and maxillofacial surgery. All of these specialties are performing surgery in an era of evolving technology, cost containment, reduced resident work hours, and a focus on patient safety. As a result, the purpose of this manuscript is to review the most recent literature and trends in craniomaxillofacial surgery simulation as it pertains to advances in: teaching methodology, technology for training, and professional development, including lifelong learning and certificate maintenance.

Recent findings: The Halstedian model of education is no longer valid in isolation as simulation continues to evolve. Advances are occurring in craniomaxillofacial simulation fidelity, via technology, validation, and implementation, though significant opportunity still exists toward total integration into training, as procedural models are limited.

Summary: Simulation in craniomaxillofacial training is not fully pervasive or integrated, but evidence exists that simulation is rapidly evolving via improvements in innovation, fidelity, teaching methodology, and ultimately, commitment to simulation as a means to improve surgical education as well as patient safety and quality.

Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.

from OtoRhinoLaryngology - Alexandros G. Sfakianakis http://ift.tt/1VF6QJr
via IFTTT

Read more Add star Mark as unread Top
Update in alar base reduction in rhinoplasty.2016-06-05 12:14:55 AM

Update in alar base reduction in rhinoplasty.: Purpose of review: The purpose of this article is to further explore the techniques available for alar base reduction by a recent review in this topic, focusing in the current advances in the field, in a clear and readable format.

Recent findings: Among the numerous techniques available, the management of cases with wide nasal base and alar flaring remains limited to three options: cinching sutures to pull in the alae together; or to use alar base excisions that remove tissue from the alar lobule to decrease flare and from inside the nostril to decrease width; and flap advancement.

Summary: Surgical modification of the nasal base is not a routine part of rhinoplasty and should be performed in a conservative manner to prevent complications like nasal stenosis. Moreover, this maneuver should always be the last one in rhinoplasty, as alar base modifications cannot be properly assessed until all other steps have been carried out.

http://ift.tt/1PwbeZX

Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.

from OtoRhinoLaryngology - Alexandros G. Sfakianakis http://ift.tt/22Gn1XW
via IFTTT

Read more Add star Mark as unread Top
CD166-mediated epidermal growth factor receptor phosphorylation promotes2016-06-05 12:14:55 AM

the growth of oral squamous cell carcinoma

via ScienceDirect Search: ESOPHAGEAL CANCER

Publication date: August 2016
Source:Oral Oncology, Volume 59
Author(s): Guodong Jia, Xu Wang, Ming Yan, Wantao Chen, Ping Zhang
CD166 has been considered a relatively specific marker of stem cells and cancer stem cells, and the altered expression of CD166 has also been reported as a prognostic marker of several other types of cancer. However, the molecular functions of CD166 in these cancer cells are largely unknown. In this study, we found that CD166 significantly enhanced epidermal growth factor receptor (EGFR) phosphorylation and prolonged epidermal growth factor (EGF)/EGFR signalling activation. In addition, EGF stimulation in CD166-overexpressing oral squamous carcinoma cells led to enhanced colony formation, invasion capacity and cytoskeletal re-organization in vitro and elevated tumourigenesis in vivo. Taken together, the results of our study identify CD166 as an intriguing therapeutic target for patients suffering from oral squamous cell carcinoma (OSCC).

from OtoRhinoLaryngology - Alexandros G. Sfakianakis http://ift.tt/22Gneu4
via IFTTT

Read more Add star Mark as unread Top
Hemostatic Properties of Polyphosphate Coacervates2016-06-05 12:14:55 AM

Degradation and

via Acta Biomaterialia

Publication date: Available online 2 June 2016
Source:Acta Biomaterialia
Author(s): Arash Momeni, Mark Joseph Filiaggi
Sodium polyphosphate is a linear polymer formed from phosphate units linked together by sharing oxygen atoms. Addition of calcium to a solution of sodium polyphosphate results in phase separation and formation of a polyphosphate coacervate best described as a polymeric rich viscoelastic material. Polyphosphate coacervate is an interesting candidate as a biomaterial based on its ability to bind with different cations and to be loaded with drugs. Here, in vitro degradation and hemostatic properties of polyphosphate coacervates are comprehensively evaluated. We show that polyphosphate coacervates degrade and dissolve at a fast rate, losing half of their original mass in a week and transforming to mainly pyrophosphate after 4 weeks. This burst dissolution phase happens earlier for the coacervate prepared from very short chain polyphosphate but overall using longer polyphosphate chains does not increase the coacervate longevity significantly. Substitution of Ca with Sr or Ba does not affect the hydrolysis of coacervates but slows down their dissolution into the media. In a whole blood clotting assay, coacervates profoundly decrease the clotting time especially when very long chain polyphosphates are used. While coacervate chain length and divalent cation type were found to significantly affect prothrombin time and thromboplastin time compared to the control, no discernible trends were observed. Platelets adhere in large numbers to coacervates, especially those containing long chain polyphosphate, but the cell morphology observed suggests that they might not to be fully activated. Overall, the long chain polyphosphate coacervate holds a great potential as a resorbable hemostatic agent.Statement of SignificanceDivalent cation additions to a sodium polyphosphate solution result in polyphosphate coacervates, or highly viscous gel-like materials, having great potential in bio-applications such as drug delivery and hemostasis. As these coacervates degrade in aqueous environments, we undertook a comprehensive evaluation to better understand the impact of polyphosphate chain length and divalent cation substitution on this hydrolytic response in order to better predict degradation behavior in the body. Furthermore, there is great interest in the role of polyphosphates in hemostasis following recent publications showing that platelets secrete polyphosphates upon thrombin stimulation. In this paper, we evaluate the hemostatic potential of polyphosphate coacervates as bulk constructs, demonstrating that indeed these materials hold great potential as a degradable hemostatic agent.
Graphical abstract

from OtoRhinoLaryngology - Alexandros G. Sfakianakis http://ift.tt/1VF6rqc
via IFTTT

Read more Add star Mark as unread Top
Pentose sugars are the preferred carbon nutrients utilized by H. pylori. The amino acids l-aspartic acid, d-alanine, and l-asparagine serve as both carbon and nitrogen sources in the metabolism of the bacterium.2016-06-05 12:14:55 AM

Elucidation of the Metabolic Network of Helicobacter pylori J99 and Malaysian Clinical Strains by Phenotype Microarray:

Abstract

Background

Helicobacter pylori colonizes almost half of the human population worldwide. H. pylori strains are genetically diverse, and the specific genotypes are associated with various clinical manifestations including gastric adenocarcinoma, peptic ulcer disease (PUD), and nonulcer dyspepsia (NUD). However, our current knowledge of the H. pylori metabolism is limited. To understand the metabolic differences among H. pylori strains, we investigated four Malaysian H. pylori clinical strains, which had been previously sequenced, and a standard strain,H. pylori J99, at the phenotypic level.

Materials and Methods

The phenotypes of the H. pylori strains were profiled using the Biolog Phenotype Microarray system to corroborate genomic data. We initiated the analyses by predicting carbon and nitrogen metabolic pathways from the H. pylori genomic data from the KEGG database. Biolog PM aided the validation of the prediction and provided a more intensive analysis of the H. pylori phenomes.

Results

We have identified a core set of metabolic nutrient sources that was utilized by all strains tested and another set that was differentially utilized by only the local strains. Pentose sugars are the preferred carbon nutrients utilized by H. pylori. The amino acids l-aspartic acid, d-alanine, and l-asparagine serve as both carbon and nitrogen sources in the metabolism of the bacterium.

Conclusion

The phenotypic profile based on this study provides a better understanding on the survival of H. pylori in its natural host. Our data serve as a foundation for future challenges in correlating interstrain metabolic differences in H. pylori.

from OtoRhinoLaryngology - Alexandros G. Sfakianakis http://ift.tt/22GntFz
via IFTTT

Read more Add star Mark as unread Top
Pseudoepitheliomatous hyperplasia mimicking esophageal squamous cell carcinoma2016-06-05 12:14:55 AM

in a patient with lye-induced esophageal stricture.:

Korean J Gastroenterol. 2014 Jun;63(6):366-8

Authors: Han JS, Lee SW, Suh KH, Kim SY, Hyun JJ, Jung SW, Koo JS, Yim HJ

Abstract

Pseudoepitheliomatous hyperplasia is a benign condition that may be caused by prolonged inflammation, chronic infection, and/or neoplastic conditions of the mucous membranes or skin. Due to its histological resemblance to well-differentiated squamous cell carcinoma, pseudoepitheliomatous hyperplasia may occasionally be misdiagnosed as squamous cell carcinoma. The importance of pseudoepitheliomatous hyperplasia is that it is a self-limited condition that must be distinguished from squamous cell carcinoma before invasive treatment. We report here on a rare case of esophageal pseudoepitheliomatous hyperplasia in a 67-year-old Korean woman with a lye-induced esophageal stricture. Although esophageal pseudoepitheliomatous hyperplasia is infrequently encountered, pseudoepitheliomatous hyperplasia should be considered in the differential diagnosis of esophageal lesions.

PMID: 24953614 [PubMed - indexed for MEDLINE]

from OtoRhinoLaryngology - Alexandros G. Sfakianakis http://ift.tt/25F3f0M
via IFTTT

Read more Add star Mark as unread Top
Lye-induced esophageal stricture2016-06-05 12:14:55 AM

Pseudoepitheliomatous hyperplasia mimicking esophageal squamous cell carcinoma in a patient with

Korean J Gastroenterol. 2014 Jun;63(6):366-8

Authors: Han JS, Lee SW, Suh KH, Kim SY, Hyun JJ, Jung SW, Koo JS, Yim HJ

Abstract

Pseudoepitheliomatous hyperplasia is a benign condition that may be caused by prolonged inflammation, chronic infection, and/or neoplastic conditions of the mucous membranes or skin. Due to its histological resemblance to well-differentiated squamous cell carcinoma, pseudoepitheliomatous hyperplasia may occasionally be misdiagnosed as squamous cell carcinoma. The importance of pseudoepitheliomatous hyperplasia is that it is a self-limited condition that must be distinguished from squamous cell carcinoma before invasive treatment. We report here on a rare case of esophageal pseudoepitheliomatous hyperplasia in a 67-year-old Korean woman with a lye-induced esophageal stricture. Although esophageal pseudoepitheliomatous hyperplasia is infrequently encountered, pseudoepitheliomatous hyperplasia should be considered in the differential diagnosis of esophageal lesions.

PMID: 24953614 [PubMed - indexed for MEDLINE]

from OtoRhinoLaryngology - Alexandros G. Sfakianakis http://ift.tt/1VF6BxV
via IFTTT

Read more Add star Mark as unread Top
Elevating the Head of the Bed for Patients With Gastroesophageal Reflux Disease2016-06-05 12:14:55 AM

[A Systematic Review of the Literature Related to Elevating the Head of the Bed for Patients With Gastroesophageal Reflux Disease: Applications in Patients After Esophageal Cancer Surgery].:

Hu Li Za Zhi. 2016 Jun;63(3):83-93

Authors: Huang HC, Fang SY

Abstract

BACKGROUND: Acid regurgitation typically worsens during nighttime sleep, which influences the quality of life of patients and potentially causes pathological changes. As much as 80% of esophageal cancer patients experience acid regurgitation following esophagectomy and reconstruction surgery. Thus, improving this symptom is important to improving the quality of life of these patients.

PURPOSE: The purpose of the present study was to evaluate the effect of elevating the head of the bed for patients with gastroesophageal reflux disease (GERD).

METHODS: A systematic review was used. Electronic databases including CINAHL (Cumulative Index to Nursing and Allied Health Literature), Cochrane Library, ProQuest, and PubMed/MEDLINE were retrieved for relevant articles that were published prior to June 2015. Keywords included "elevating the head of the bed/bed position/body position", "flat", "reflux", and the MeSh term "gastroesophageal reflux". A total of 37 articles that matched the search criteria were extracted. After screening the topics and deleting repetitions, three randomized controlled studies and one quasi-experimental designed study were selected.

RESULTS: Results of this systemic review revealed that elevating the head of the bed for patients with GERD reduced the duration of exposure of the the esophagus to an acid environment. Furthermore, patients perceived that this intervention not only improved symptoms such as regurgitation and burn sensation without medication but also relieved symptoms better than taking medications alone.

CONCLUSIONS: The reviewed studies support that elevating the head of the bed is an easy and effective way to alleviate the symptoms of acid regurgitation. A height of elevation of 20 to 28 cm is recommended in the literature. The slope of the elevated bed must also be considered. Elevating the head of the bed may be useful for improving acid regurgitation among esophageal cancer patients after surgery. A randomized controlled study may be used to validate this effect in the future.

PMID: 27250962 [PubMed - in process]

from OtoRhinoLaryngology - Alexandros G. Sfakianakis http://ift.tt/25F3OHJ
via IFTTT

Read more Add star Mark as unread Top
Improvement of cisplatin-related renal dysfunction by synthetic ghrelin2016-06-05 12:14:55 AM

a prospective randomised phase II trial.:

Br J Cancer. 2016 Jun 2;

Authors: Yanagimoto Y, Takiguchi S, Miyazaki Y, Makino T, Takahashi T, Kurokawa Y, Yamasaki M, Miyata H, Nakajima K, Hosoda H, Kangawa K, Mori M, Doki Y

Abstract

BACKGROUND: Ghrelin, a 28-amino acid peptide predominantly produced by the stomach, exerts powerful renal protective effects by increasing levels of insulin-like growth factor-1 (IGF-1). The aim of this study was to evaluate the effects of ghrelin on the incidence of renal dysfunction in patients receiving cisplatin-based chemotherapy.

METHODS: Forty patients with oesophageal cancer receiving cisplatin-based chemotherapy were assigned to either the ghrelin group (n=20), which received ghrelin (0.5 μg kg(-1) h(-1)) for 5 days, or a placebo group (n=20). The primary endpoint was serum creatinine. Secondary endpoints were serum cystatin C, chemotherapy-related adverse events, changes in serum ghrelin-related hormone levels, correlation between markers of renal injury and hormone concentrations, and effects on the second cycle of chemotherapy.

RESULTS: Blood acyl ghrelin, total ghrelin, and IGF-1 concentrations on day 4 were significantly higher in the ghrelin group. The renal dysfunction, serum creatinine and cystatin C levels, dose reduction, and delay in the initiation of the second cycle of chemotherapy were lower in the ghrelin group than in the control group. Serum creatinine levels were significantly correlated with serum IGF-1 levels.

CONCLUSION: Continuous synthetic ghrelin administration during cisplatin-based chemotherapy attenuated renal dysfunction and harmful effects on subsequent chemotherapy, possibly by increasing IGF-1 levels.British Journal of Cancer advance online publication, 2 June 2016; doi:10.1038/bjc.2016.160 www.bjcancer.com.

PMID: 27253174 [PubMed - as supplied by publisher]

from OtoRhinoLaryngology - Alexandros G. Sfakianakis http://ift.tt/1t9JUqU
via IFTTT

Read more Add star Mark as unread Top
Autophagy markers LC3B and p62 in esophageal adenocarcinomas.2016-06-05 12:14:55 AM

Prognostic relevance of

Oncotarget. 2016 ;

Authors: Adams O, Dislich B, Berezowska S, Schläfli AM, Seiler CA, Kroell D, Tschan MP, Langer R

Abstract

Esophageal adenocarcinomas (EAC) are aggressive tumors with considerable rates of chemoresistance. Autophagy is a lysosome-dependent degradation process, characterized by the formation of vesicles called autophagosomes, and has been implicated in cancer. Protein light chain 3 B (LC3B) and p62 are associated with autophagosomal membranes and degraded. We aimed to assess the impact of basal autophagy on EAC. In EAC cell lines, an increase in LC3B and p62 was observed with increasing concentrations of the autophagy inhibitor chloroquine, which indicates functional basal autophagy. LC3B and p62 immunohistochemistry was performed on primary resected EAC. High LC3B and p62 expression was associated with earlier tumor stages (p < 0.05). High nuclear and cytoplasmic p62 staining were associated with a better prognosis (p = 0.006; p = 0.028). Various combinations of p62 expression with or without LC3B expression identified different prognostic groups. Tumors with low total p62 (p = 0.007) or low LC3B/low p62 expression had the worst outcome (p = 0.007; p = 0.005). A combination score of dot-like/cytoplasmic p62 and nuclear p62 staining was an independent prognostic parameter (p = 0.033; HR = 0.6). This study highlights the potential significance of basal autophagy in EAC biology. Tumors with low LC3B and p62 expression show the most aggressive behavior and may be candidates for autophagy regulating therapeutics.

PMID: 27250034 [PubMed - as supplied by publisher]

from OtoRhinoLaryngology - Alexandros G. Sfakianakis http://ift.tt/25F3b0V
via IFTTT

Read more Add star Mark as unread Top
Main upper gastrointestinal diseases and Helicobacter pylori infection2016-06-05 12:14:55 AM

[The changes of main upper gastrointestinal diseases and Helicobacter pylori infection status in the past thirty five years].:

Zhonghua Nei Ke Za Zhi. 2016 Jun;55(6):440-4

Authors: Zhang H, Xue Y, Zhou LY, Liu X, Suo BJ

Abstract

OBJECTIVE: To study the spectrum of upper gastrointestinal diseases and infection rate of Helicobacter pylori(Hp)in our hospital during the past 35 years.

METHODS: Patients who were 16 or older with duodenal ulcer, gastric ulcer, reflux esophagitis, gastric cancer and esophageal cancer diagnosed by gastroscopy and pathology were retrospectively enrolled in our study from January 1980 to December 2014.Patients with chronic superficial gastritis, chronic atrophic gastritis or Hp infection from January 1989 to December 2014 were also included in our study according to the same diagnostic criteria.The incidences of diseases and the infection rates of Hp were studied.

RESULTS: A total of 213 495 patients underwent gastroscopy in our department during the past 35 years.The overall diagnostic rates of duodenal ulcer, gastric ulcer, reflux esophagitis, gastric cancer and esophageal cancer were 9.87%, 3.79%, 6.66%, 1.59% and 0.66% respectively.There were 183 426 patients receiving gastroscopy in our department from January 1989 to December 2014. The overall endoscopic diagnosis rates of chronic superficial gastritis and chronic atrophic gastritis were 49.83% and 22.43% respectively.The overall infection rate of Hp was 36.18%, which had a declining trend consistent with peptic ulcer (all P=0.000). Yet, the prevalence of reflux esophagitis, chronic superficial gastritis and chronic atrophic gastritis were increasing (all P=0.000). The diagnostic rates of gastric cancer and esophageal cancer were persistent (P=0.266, P=0.156).

CONCLUSIONS: The Hp infection during years has been decreasing, consistent with the declining tendency of peptic ulcer.On the other hand, reflux esophagitis, chronic superficial gastritis and chronic atrophic gastritis show an ascendant trend.The proportion of patients with gastric cancer and esophageal cancer is relatively stable.

PMID: 27256605 [PubMed - in process]

from OtoRhinoLaryngology - Alexandros G. Sfakianakis http://ift.tt/1Zod0N0
via IFTTT

Read more Add star Mark as unread Top
Aprepitant, granisetron, and dexamethasone versus palonosetron and dexamethasone for prophylaxis of cisplatin-induced nausea and vomiting2016-06-05 12:14:55 AM

in patients with upper gastrointestinal cancer: a randomized crossover phase II trial (KDOG 1002).:

Anticancer Drugs. 2016 May 31;

Authors: Ishido K, Higuchi K, Azuma M, Sasaki T, Tanabe S, Katada C, Yano T, Wada T, Koizumi W, Kitasato Digestive Disease & Oncology Group

Abstract

We conducted a randomized trial to compare the safety and effectiveness of aprepitant, granisetron, and dexamethasone (AGD) with those of palonosetron and dexamethasone (PD) in patients who received highly emetogenic chemotherapy (HEC). Patients with esophageal or gastric cancer who were scheduled to receive HEC including at least 60 mg/m of cisplatin as the first-line treatment were randomly assigned to receive AGD (oral aprepitant 125 mg on day 1 and 80 mg on days 2-3; intravenous granisetron 3 mg on day 1; intravenous dexamethasone 6.6 mg on day 1 and oral dexamethasone 4 mg on days 2-3) or PD (intravenous palonosetron 0.75 mg on day 1; intravenous dexamethasone 13.2 mg on day 1 and oral dexamethasone 8 mg on days 2-3). The primary endpoint was a complete response during the overall study period (0-120 h after the start of chemotherapy) in the first cycle. Eighty-five patients were enrolled, and 84 were eligible. The complete response rate did not differ between the treatment groups, but the proportion of patients with no vomiting was significantly higher in the AGD group than in the PD group (81.4 vs. 58.5%; P=0.031). The results of a quality-of-life survey indicated that the proportion of patients with no or minimal impact on daily life in the vomiting domain was significantly higher in the AGD group (79.1 vs. 53.7%; P=0.020). The primary endpoint of complete response was not achieved, but AGD seems to be more effective than PD for the prevention of HEC-induced vomiting.

PMID: 27254283 [PubMed - as supplied by publisher]

from OtoRhinoLaryngology - Alexandros G. Sfakianakis http://ift.tt/1Zocsqs
via IFTTT

Read more Add star Mark as unread Top

Reflections on Ali, In Three Parts – Sports On Earth2016-06-05 12:23:07 AM

images?q=tbn:ANd9GcTAppZ_mzbsLp2qV7TWJN866aJFze0FMZZ7rnwxoEb2_yKn0jRHpTGkVXV7UG5n-qjFImcUh0M

Reflections on Ali, In Three Parts
Sports On Earth
Frazier died from liver cancer in 2011, still waiting for that face-to-face truce with Ali. They once were … Then came Ali-Frazier I, II and III in the 1970s, and Ali spent each of them unleashing his tongue as well as his fists against his glib …

and more »

from #ORL-AlexandrosSfakianakis via simeraentaxei on Inoreader http://ift.tt/24qvXzK
via IFTTT Medicine by Alexandros G.Sfakianakis,Anapafseos 5 Agios Nikolaos,Crete 72100,Greece,tel :00302841026182 & 00306932607174

Head and Neck Diseases by Alexandros G.Sfakianakis

Αρχειοθήκη ιστολογίου

! # Ola via Alexandros G.Sfakianakis on Inoreader

Η λίστα ιστολογίων μου

Κυριακή 5 Ιουνίου 2016

OtoRhinoLaryngology & Medicine,New Articles,June 5th,2016,a

Abstract

Objective

Methods

Results

Conclusion

Keywords:

Graphical abstract

Abstract

Background

Materials and Methods

Results

Conclusion

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Αρχειοθήκη ιστολογίου